Theodore Schroeder, Director at Hyperion Therapeutics, holds 11.99K shares in Nabriva Therapeutics (Ticker: NBRVF), holds 11.01K shares in Collegium Pharmaceutical (Ticker: COLL), holds 0.00 shares in Hyperion Therapeutics (Ticker: HPTX).
Theodore Schroeder latest transaction was an Uninformative Sell of $646.50.
What was Theodore Schroeder's most profitable transaction?
Theodore Schroeder’s most profitable transaction was an Informative Buy of NBRVF stock on August 28, 2019. The return on the trade was -70.40%.
What is Theodore Schroeder's role in Hyperion Therapeutics?
Theodore Schroeder's role in Hyperion Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.